DIAGNOSTIC-VALUE OF CLONALITY OF SURFACE-IMMUNOGLOBULIN LIGHT AND HEAVY-CHAINS IN MALIGNANT LYMPHOPROLIFERATIVE DISORDERS

被引:15
作者
BATATA, A
SHEN, B
机构
[1] Lymphoma/Leukemia Research Center, Department of Pathology, Cox Institute, Wright State University School of Medicine, Dayton, Ohio
关键词
SURFACE IMMUNOGLOBULIN; L-CHAIN; H-CHAIN; CLONALITY; DIFFERENTIAL DIAGNOSIS; CHRONIC LYMPHOID LEUKEMIAS; NON-HODGKINS LYMPHOMA;
D O I
10.1002/ajh.2830430407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cell suspensions from the peripheral blood of B-chronic lymphoid leukemias (B-CLL, n = 274) and reactive lymphocytosis (RLC, n = 132) and from solid tissue samples of B-non-Hodgkin's lymphoma (B-NHL, n = 466) and reactive lymphadenopathy (RLA, n = 324) were analyzed to evaluate the diagnostic value of clonality of L- and H- chains in B-CLL and B-NHL. Cutoff levels for monoclonal L-chain (mono-L) and monoclonal H-chain (mono-H) were defined. In B-CLL , the association patterns of L- and H- chains were as follows: mono-L/mono-H, 245 cases (89.42%); mono-L/polyclonal H chain (poly-H), 4 (1.46%); polyclonal L chain (poly-L)/mono-H, 2 (0.73%); poly-L/poly-H, 2 (0.73%); undetected (und) -L/mono-H, 6 (2.19%); and und-L/und-H, 15 (5.47%). In B-NHL, the association patterns were mono-L/mono-H, 433 cases (92.92%); mono-L/poly-H, 4 (0.86%); poly-L/mono-H, 8 (1.72%); poly-L/poly-H, 2 (0.43%); und-L/mono-H, 4 (0.86%); and und-L/und-H, 15 (3.22%). Monoclonality of H chains are complementary to L-chain restriction, especially in the cases with poly-L or und-L, and should be considered as a positive criterion in determining surface immunoglobulin (SIg) clonality. Monoclonality of SIg assessed by both L and H chains is both sensitive and specific for the diagnosis of B-CLL and B-NHL, and their differentiation from RLC and RLA, since none of the cases of RLC and RLA showed monoclonal SIg. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 22 条
[1]  
AISENBERG AC, 1983, BLOOD, V61, P469
[2]  
[Anonymous], 1982, CANCER, V49, P2112
[3]  
BATATA A, 1992, CANCER-AM CANCER SOC, V69, P1021, DOI 10.1002/1097-0142(19920215)69:4<1021::AID-CNCR2820690432>3.0.CO
[4]  
2-U
[5]  
BATATA A, 1991, CANCER-AM CANCER SOC, V68, P355, DOI 10.1002/1097-0142(19910715)68:2<355::AID-CNCR2820680225>3.0.CO
[6]  
2-7
[7]   PROPOSALS FOR THE CLASSIFICATION OF CHRONIC (MATURE) B-LYMPHOID AND T-LYMPHOID LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (06) :567-584
[8]  
BINET J L, 1989, Annals of Internal Medicine, V110, P236
[9]  
FOON KA, 1986, BLOOD, V68, P1
[10]  
GRIESSER H, 1989, BLOOD, V73, P1402